Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-06-15ABEO144Silverstein Christine Berni plan to sell securities of ABEONA THERAPEUTICS INC. under Form 144MEDIUM
Silverstein Christine Berni filed Form 144 to notify SEC of plan to sell 18160 units of ABEONA THERAPEUTICS INC. securities around 2026-06-15, with aggregate market value of $103,695.00. The total outstanding units is 56995144.0. The amount planned to be sold represents 0.03% of total outstanding units; ...
Small CapBiotechnology
2026-06-15ANAB144DENNIS MULROY plan to sell securities of ANAPTYSBIO, INC. under Form 144MEDIUM
DENNIS MULROY filed Form 144 to notify SEC of plan to sell 20000 units of ANAPTYSBIO, INC. securities around 2026-06-15, with aggregate market value of $1,153,014.00. The total outstanding units is 29100902.0. The amount planned to be sold represents 0.07% of total outstanding units; Recent transactions in past 3 month...
Small CapBiotechnology
2026-06-15ARDX144MICHAEL RAAB plan to sell securities of ARDELYX INC under Form 144MEDIUM
MICHAEL RAAB filed Form 144 to notify SEC of plan to sell 125000 units of ARDELYX INC securities around 2026-06-15, with aggregate market value of $711,250.00. The total outstanding units is 247029387.0. The amount planned to be sold represents 0.05% of total outstanding units; Recent transactions in past 3 months incl...
Small CapBiotechnology
2026-06-15ABOS144DERRELL PORTER plan to sell securities of ACUMEN PHARMACEUTICALS, INC. under Form 144MEDIUM
DERRELL PORTER filed Form 144 to notify SEC of plan to sell 6460 units of ACUMEN PHARMACEUTICALS, INC. securities around 2026-06-15, with aggregate market value of $15,148.70. The total outstanding units is 72227580.0. The amount planned to be sold represents 0.01% of total outstanding units; ...
Micro CapBiotechnology
2026-06-15ADPT144Harlan Robins plan to sell securities of Adaptive Biotechnologies Corporation under Form 144MEDIUM
Harlan Robins filed Form 144 to notify SEC of plan to sell 100000 units of Adaptive Biotechnologies Corporation securities around 2026-06-15, with aggregate market value of $1,746,000.00. The total outstanding units is 160044392.0. The amount planned to be sold represents 0.06% of total outstanding units; Recent transa...
Mid CapBiotechnology